Mechanism of losartan
Pro Research Analysisby 
Searched over 200M research papers
Mechanism of Losartan: A Comprehensive Overview
Introduction to Losartan and Its Primary Mechanism
Losartan is a widely used medication primarily known for its role as an angiotensin II type 1 (AT1) receptor antagonist. It is commonly prescribed for the treatment of hypertension and has a variety of other therapeutic effects. The primary mechanism of losartan involves blocking the AT1 receptors, which prevents angiotensin II from binding and exerting its vasoconstrictive effects, thereby lowering blood pressure .
Interaction with Angiotensin-Converting Enzyme (ACE)
Recent studies have explored the interaction between losartan and the angiotensin-converting enzyme (ACE). Losartan has been shown to interact with the sACE enzyme, potentially blocking its activity and intracellular signaling. This interaction suggests a novel mechanism of action for losartan, which could have significant implications for its effects on hypertension .
Biotransformation and Metabolism
Losartan undergoes biotransformation in the liver, where it is converted into a more active carboxylic acid metabolite, E3174. This conversion is catalyzed by cytochrome P450 enzymes, specifically CYP2C9 and CYP3A4. The metabolite E3174 is pharmacologically more active than losartan itself, contributing significantly to its therapeutic effects .
Effects on Myocardial Fibrosis and Endothelial Function
Losartan has been found to inhibit myocardial fibrosis by suppressing the endothelial-to-mesenchymal transition (EndMT) via the TGF-β/Smad signaling pathway. This effect is particularly evident in spontaneous hypertensive rats, where losartan treatment significantly reduces myocardial fibrosis and EndMT . Additionally, losartan improves endothelial function in patients with non-insulin-dependent diabetes mellitus (NIDDM), enhancing endothelium-dependent dilation of resistance vessels .
Anti-Inflammatory and Analgesic Properties
Losartan exhibits anti-inflammatory properties by inhibiting the production of inflammatory cytokines such as IL-1β and TNF-α in the dorsal root ganglia. This mechanism is particularly beneficial in alleviating chemotherapy-induced neuropathic pain . Furthermore, losartan reduces the activation of nuclear factor κB (NF-κB) and mitogen-activated protein kinases (MAPKs), which are critical pathways in the inflammatory response, thereby providing protective effects in conditions like acute lung injury (ALI) .
Impact on Lipid Peroxidation and Atherosclerosis
In animal models, losartan has been shown to inhibit LDL lipid peroxidation, which plays a crucial role in the development of atherosclerosis. By reducing lipid peroxidation, losartan significantly decreases the mean atherosclerotic lesion area, highlighting its potential antiatherogenic effects .
Neuroprotective Effects
Losartan also offers neuroprotective benefits, particularly in the context of cerebral ischemia/reperfusion injury. It reduces apoptosis by modulating the β-arrestin1-mediated phosphorylation of Akt, thereby enhancing cell survival and reducing brain damage .
Conclusion
Losartan is a multifaceted drug with a primary mechanism of action as an AT1 receptor antagonist. Its therapeutic effects extend beyond blood pressure regulation, encompassing anti-inflammatory, anti-fibrotic, and neuroprotective properties. The drug's ability to interact with ACE, undergo biotransformation to a more active metabolite, and inhibit key inflammatory pathways underscores its versatility in treating various conditions. Understanding these mechanisms provides a comprehensive view of losartan's potential benefits in clinical practice.
Sources and full results
Most relevant research papers on this topic